Bausch & Lomb announced a voluntary recall of intraocular lenses on its enVista platform on March 27, 2025, due to reports of toxic anterior segment syndrome (TASS), a potential complication in cataract surgery. The recall may raise short-term concerns about product safety and regulatory scrutiny.
Following this news, Bausch & Lomb's stock price fell over 10% on that same day.
To receive more information, please fill out the form.
